Cogent Biosciences Company Contacts

Cogent Biosciences

http://www.cogentbio.com
Cogent Biosciences is a biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the... Read More
Contacts

Country

United States

City

Waltham

Headquarters

Waltham, Massachusetts

Profile

Founded

2014

Industry

Biotechnology Research

Size

51 - 200

Specialties

gastrointestinal stromal tumors (GIST), Oncology, Systemic Mastocytosis, kinase inhibitors

Funding

Total Rounds

10

Last Round

Mon Feb 12 2024

Last Round Series

Post IPO equity

Last Round Raised

$ 225,000,000